NICE Single Technology Appraisal Guidance No 189
Sorafenib for the treatment of advanced hepatocellular
This NICE guidance was published on 26 May 2010.
The web reference for the appraisal and other related documents is:
NHSScotland should note that:
1. Recommendations of NICE Single Technology
Appraisals (STAs) have no status in NHSScotland.
2. NHS boards should adhere to the Scottish
Medicines Consortium (SMC) advice.
SMC published a Statement of Advice (482/08) on
this medication for this indication in January 2011. This
Sorafenib (Nexavar®) is not
recommended for use within NHSScotland for the treatment of
Access the advice of SMC
3. There is no material difference between the
recommendations of the NICE STA and SMC.
Published Date: 26 May 2010